These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27598744)

  • 1. Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers.
    Herfarth HH; Jackson S; Schliebe BG; Martin C; Ivanova A; Anton K; Sandler RS; Long MD; Isaacs KL; Osterman MT; Sands BE; Higgins PD; Lewis JD
    Inflamm Bowel Dis; 2017 Jan; 23(1):14-22. PubMed ID: 27598744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Challenges in the organization of investigator initiated trials: in transplantation medicine].
    Schnitzbauer AA; Lamby PE; Mutzbauer I; von Hassel J; Geissler EK; Schlitt HJ
    Chirurg; 2011 Mar; 82(3):249-54. PubMed ID: 21416397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT).
    Blümle A; Wollmann K; Bischoff K; Kapp P; Lohner S; Nury E; Nitschke K; Zähringer J; Rücker G; Schumacher M
    BMC Med Res Methodol; 2021 Aug; 21(1):182. PubMed ID: 34465296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design.
    Nury E; Bischoff K; Wollmann K; Nitschke K; Lohner S; Schumacher M; Rücker G; Blümle A
    BMC Med Res Methodol; 2020 Oct; 20(1):246. PubMed ID: 33008297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Institution/investigator-initiated clinical trials in Canada.
    Sedgeworth J; Derewlany L
    Can J Clin Pharmacol; 2006; 13(2):e236-9. PubMed ID: 16873897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic principles, planning and implementation of non-commercial clinical trials].
    Finger RP; Coch C; Coenen M; Mengel M; Hartmann G; Holz FG
    Ophthalmologe; 2011 Jan; 108(1):25-32. PubMed ID: 21181167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries.
    Ito T
    PLoS One; 2016; 11(2):e0148455. PubMed ID: 26848574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality and completeness of data documentation in an investigator-initiated trial versus an industry-sponsored trial.
    Patwardhan S; Gogtay N; Thatte U; Pramesh CS
    Indian J Med Ethics; 2014; 11(1):19-24. PubMed ID: 24509104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of NCI-mandated scientific review on protocol development and content.
    Ning N; Yan J; Xie XJ; Gerber DE
    J Natl Compr Canc Netw; 2015 Apr; 13(4):409-16. PubMed ID: 25870377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Development of Investigator-Initiated Clinical Trials in Surgical Oncology.
    McDonald HG; Cassim EB; Harper MM; Burke EE; Marcinkowski EF; Cavnar MJ; Pandalai PK; Kim J
    Surg Oncol Clin N Am; 2023 Jan; 32(1):13-25. PubMed ID: 36410913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of Directive 2001/20/EC for investigator-initiated trials in the paediatric population--a field report.
    Welzing L; Harnischmacher U; Weyersberg A; Roth B
    Eur J Pediatr; 2007 Nov; 166(11):1169-76. PubMed ID: 17333274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Challenges of Investigator-initiated Clinical Trials to Support 
the New Drug Development].
    Bai H; Zhang S
    Zhongguo Fei Ai Za Zhi; 2022 Jul; 25(7):511-516. PubMed ID: 35899450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigator-initiated Randomized Controlled Trials in Infectious Diseases: Better Value for Money for Registration Trials of New Antimicrobials.
    Paul M; Harbarth S; Huttner A; Thwaites GE; Theuretzbacher U; Bonten MJM; Leibovici L
    Clin Infect Dis; 2021 Apr; 72(7):1259-1264. PubMed ID: 32619238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list.
    Speich B; von Niederhäusern B; Blum CA; Keiser J; Schur N; Fürst T; Kasenda B; Christ-Crain M; Hemkens LG; Pauli-Magnus C; Schwenkglenks M; Briel M;
    J Clin Epidemiol; 2018 Apr; 96():73-83. PubMed ID: 29292203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learned from investigator-initiated clinical trials for localized pancreatic cancer.
    Tsai S; Evans DB
    J Surg Oncol; 2022 Jan; 125(1):69-74. PubMed ID: 34897709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal and ethical obligations to conduct a clinical drug trial in Australia as an investigator initiated and sponsored study for an overseas pharmaceutical company.
    Beran RG
    Med Law; 2004; 23(4):913-24. PubMed ID: 15685926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the efficiency of clinical trials by standardizing processes for Investigator Initiated Trials.
    Mudaranthakam DP; Phadnis MA; Krebill R; Clark L; Wick JA; Thompson J; Keighley J; Gajewski BJ; Koestler DC; Mayo MS
    Contemp Clin Trials Commun; 2020 Jun; 18():100579. PubMed ID: 32510004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to participation in industry-sponsored clinical trials in pediatric type 2 diabetes.
    Farrell R; Bethin K; Klingensmith G; Tamborlane WV; Gubitosi-Klug R
    Pediatr Diabetes; 2017 Nov; 18(7):574-578. PubMed ID: 27807915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.